INTENSITY-MODULATED RADIOTHERAPY
Clinical trials for INTENSITY-MODULATED RADIOTHERAPY explained in plain language.
Never miss a new study
Get alerted when new INTENSITY-MODULATED RADIOTHERAPY trials appear
Sign up with your email to follow new studies for INTENSITY-MODULATED RADIOTHERAPY, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Could a drug cocktail shrink sarcomas before surgery?
Disease control Recruiting nowThis phase 2 trial tests whether giving a drug called anlotinib (which cuts off tumor blood supply) along with immunotherapy (penpulimab) and radiation before surgery can improve outcomes for people with soft tissue sarcoma in the arms, legs, or trunk. The study will enroll 30 ad…
Matched conditions: INTENSITY-MODULATED RADIOTHERAPY
Phase: PHASE2 • Sponsor: Cancer Institute and Hospital, Chinese Academy of Medical Sciences • Aim: Disease control
Last updated Jun 27, 2026 13:02 UTC
-
Could less be more? Radiation-Only trial for nasopharyngeal cancer
Disease control Recruiting nowThis study looks at whether using only targeted radiation (IMRT) can effectively control stage IB nasopharyngeal cancer in patients without high-risk features. About 169 adults aged 18-70 with newly diagnosed, early-stage disease will be followed to see how many remain cancer-fre…
Matched conditions: INTENSITY-MODULATED RADIOTHERAPY
Sponsor: Qiaojuan Guo • Aim: Disease control
Last updated Jun 27, 2026 09:00 UTC